ANXA2 and endometrial cancer: Herrero et al. (2019) reported that plasma extracellular vesicle ANXA2 was elevated in endometrial cancers with poor prognostic features, including non-endometrioid, high-grade, advanced stage disease with a high risk of recurrence [18].